1 – 10 of 219
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
- Increased intestinal permeability in primary Sjögren's syndrome and multiple sclerosis
- Krig och skogsvård: bilder av mikrober och människor i antibiotikaresistensens tid
- First-in-Man Safety, Tolerability, and Pharmacokinetics of a Novel and Highly Selective Inhibitor of Matrix Metalloproteinase-12, FP-025 : Results from Two Randomized Studies in Healthy Subjects
-
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer
Kaminska, Kamila LU ; Akrap, Nina LU ; Staaf, Johan LU
; Alves, Carla L
; Ehinger, Anna
LU
; Ebbesson, Anna
LU
; Hedenfalk, Ingrid
LU
; Beumers, Lukas
LU
; Veerla, Srinivas
LU
and Harbst, Katja
LU
, et al.
(2021)
In Breast cancer research : BCR
23(1).
p.26-26
Mark
- A broad spectrum anti-bacterial peptide with an adjunct potential for tuberculosis chemotherapy
- Membrane Interactions of Virus-like Mesoporous Silica Nanoparticles
- 2020
- Protocol for Proteome Analysis of Group A Streptococcus
- Influence of obestatin on the histological development of the small intestine in piglets during the first week of postnatal life
- Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and rivaroxaban in atrial fibrillation
- Favorable Pharmacokinetic Characteristics of Extended-Half-Life Recombinant Factor VIII BAY 94-9027 Enable Robust Individual Profiling Using a Population Pharmacokinetic Approach